Clinical Research Details

Clinical Research

1VIT15043: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure with Iron Deficiency

Study Description

The purpose of the study is to see if Injectafer® will work to reduce death, hospitalizations associated with heart failure and improve daily function when administered to treat heart failure with iron deficiency and reduced ejection fraction. This study is also being done to see if Injectafer® is safe as a treatment for people in heart failure with iron deficiency.

Investigators


Principal Investigator
Francesco Franchi, M.B.Ch.B. (M.D.)
Medicine

Sub Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Fabiana Rollini, M.B.Ch.B. (M.D.)
Medicine